Associated Papers
miRNA-Mediated Regulation of γ-Globin to β-Globin Switching: Therapeutic Potential in β-Hemoglobinopathies.
Alotaibi D et al.
International Journal of Molecular Sciences, 2026
Hemoglobin Dieppe (HBB:c. 383A > G): A Rare Dominant β-Thalassemia in an Iraqi Kurdish Family.
Osman TJ et al.
Hemoglobin, 2025
Utilization of multiple genetic methods for prenatal diagnosis of rare thalassemia variants.
Jiang F et al.
Frontiers in Genetics, 2023
Evaluation of in silico predictors on short nucleotide variants in HBA1, HBA2, and HBB associated with haemoglobinopathies.
Tamana S et al.
Elife, 2022
36453528 (PubMed )
Supplement: elife-79713-supp2.xlsx › Input-Full_dataset
Dominant β-Thalassemia Phenotype Caused by Hb Dieppe (HBB: c.383A>G): Another Case Report.
Chen HQ et al.
Hemoglobin, 2021
Molecular Characterization and Disease-Related Morbidities of β-Thalassemia Patients from the Northeastern Part of Iraq.
Amin S et al.
International Journal of General Medicine, 2020
Red blood cells free α-haemoglobin pool: a biomarker to monitor the β-thalassemia intermedia variability. The ALPHAPOOL study.
Vasseur C et al.
British Journal of Haematology, 2017
Haematological and electrophoretic characterisation of β-thalassaemia in Yunnan province of Southwestern China.
Zhang J et al.
Bmj Open, 2017
Genetic heterogeneity of the β-globin gene in various geographic populations of Yunnan in southwestern China.
Zhang J et al.
Plos One, 2015
Novel dominant β-thalassemia: Hb Boston-Kuwait [codon 139/140(+T)].
Croteau SE et al.
Pediatric Blood & Cancer, 2013
A De Novo Heterozygous Variant (HBB: c.379delG, p.Val127Cysfs*32) Associated with a Mild β-Thalassemia Intermedia Phenotype in a Turkish Child.
Gürlek-Gökçebay D et al.
Hemoglobin, 0
Select a paper to view details